Synergy Pharma (SGYP) Files $250M Mixed Shelf

Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $250 million of Common Stock, Preferred Stock, Warrants, Units, or any combination thereof.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Scribe Therapeutics prices IPO at $15 per share on Nasdaq
• SK Group and Nvidia announce $500B+ AI infrastructure partnership
• China SXT Pharmaceuticals closes $9M registered direct offering